Obsidian Therapeutics is developing a new generation of controllable cell and gene therapies to safely and effectively treat serious diseases like cancer using its proprietary cytoDRiVE™ platform to precisely regulate protein levels and activity.
| Headquarters: | Cambridge, MA |
| Website | www.obsidiantx.com |
| Pipeline | Preclinical |
| @Obsidian_tx | |
| Partners | Celgene |